Healthcare - Biotechnology - NASDAQ - US
$ 3.02
0.667 %
$ 2.53 M
Market Cap
-3.15
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--56.41%
EBIT
Estimate
93.20%
Net Income
Estimate
--74.75%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Sonnet BioTherapeutics Holdings, Inc.
SONN has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SONN
EBIT FORECAST
EBIT Forecast Chart SONN
NET INCOME FORECAST
Net Income Chart SONN